ATAGI advice on Rotarix® to replace RotaTeq®

3 July 2017

After 1 July 2017, Rotarix® will be the only rotavirus vaccine used under the National Immunisation Program in Australia for children commencing their childhood schedule, replacing RotaTeq® in Western Australia, South Australia, Victoria and Queensland.

The oral rotavirus vaccine Rotarix® (given in a 2-dose schedule) will replace RotaTeq® (given in a 3-dose schedule) in Western Australia, South Australia, Victoria and Queensland from 1 July 2017. Rotarix® is administered at approximately 2 months (from 6 weeks) and 4 months of age. The main difference between Rotarix® age restrictions (compared to Rotateq®) is that the 1st dose must be administered prior to 15 weeks of age and the 2nd dose prior to 25 weeks of age.

 

During the brand switch period, some infants from these states may potentially receive fewer doses than routinely scheduled when using the RotaTeq® brand. The specific recommendations will vary depending on the age of the child and rotavirus vaccination history.

ATAGI advice is available on the Immunise Australia website.